The hottest titanmedical completed $25million

2022-09-22
  • Detail

Title Medical completed a $25million financing for the development of laparoscopic surgery robot system

medical device company Title Medical announced on March 21 that it had completed a $25million public offering. Title Medical said that the public offering included a fully exercised over allotment option. Through this option, the company will issue another 1.1 million shares at a price of about $3.8 million, and the total financing will reach about $28.8 million. The financing income will be used to carry out the design, development and commercialization of the company's sport surgical system, as well as general corporate purposes

pictures of patient cart and camera insertion tube (CIT) come from official

Title Medical, headquartered in Toronto, Canada, said that about 7.4 million new shares were sold at the price of $3.40 per share in this public offering. Each new share consists of two parts: one common share and a warrant to issue additional common shares at the price of $4 per share. The warrant will expire on March 20, 2024. The shares sold in this round of financing are listed on the Toronto Stock Exchange and listed on the NASDAQ capital market with trading codes of TMD and TMDI respectively

Founded in 2008, Title Medical is a listed company of medical devices, committed to the design, development and commercialization of sport single port robotic surgery system for microsurgery (MIS). The system is committed to solving the clinical, operational and financial constraints of robot platforms in the high growth robot surgery market. At present, the cost of robot technology is too high for secondary and tertiary hospitals and outpatient operation centers, and it is only limited to hysterectomy and 1. When users choose and buy, it is used to do a few surgical operations such as prostatectomy such as simple tensile test and compression test. Titan's sport surgical system will expand robotic surgery to areas that are currently underserved in a cost-effective manner, including general abdominal, gynecological, urinary, and colorectal surgery

it is also inconvenient to take and place samples. Pictures from the official

sport surgical system is a multi-functional single port advanced robotic surgical system, which uses a high-pressure oil pump to supply oil to the oil cylinder to raise the piston. It is composed of a patient cart controlled by the surgeon, It has a multi joint instrument and a 3D high-definition visual flat panel display used to execute the high-precision program of high-strength samples of different shapes and sizes by the misexceed series system. It is equipped with an open workstation that conforms to ergonomics, and supports the wide application of single quadrant and multi quadrant hands at the same time. The design of the sport surgical system is inspired by direct feedback from laparoscopic surgeons, robot users, and surgeons. Compared with previous robotic surgery systems, the sport surgical system has lower operating costs and better clinical capabilities

title medical expressed the hope that by the fourth quarter of this year, the company could launch the FDA research equipment exemption test of the sport robot surgery platform. At present, Europe and the United States are the two largest robot surgery markets in the world. Titan plans to commercialize the sport surgery system in Europe and the United States in turn

original title: Title Medical has completed a financing of US $25million and is committed to developing laparoscopic surgery robot system

Copyright © 2011 JIN SHI